Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:27 AM UTC
| NCT Number | NCT06943755 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 440 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Exelixis |
| Last Updated on CT.gov | March 24, 2026 (3 weeks ago) |
As of April 17, 2026: Clinical trial NCT06943755 is currently recruiting participants. This clinical trial study for neuroendocrine tumors is actively seeking new participants at 7 locations across the United States. The study is sponsored by Exelixis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06943755 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06943755 was last updated 3 weeks ago (March 24, 2026). HelloStudys verifies this status automatically.